# Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel

> **NCT01643031** · PHASE4 · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 500 (estimated)

## Conditions studied

- Diabetes Mellitus
- Coronary Disease

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Continued clopidogrel

## Key facts

- **NCT ID:** NCT01643031
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2013-06-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01643031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01643031, "Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01643031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*